Literature DB >> 12586134

PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke.

Mary Lou P J van Goor1, Encarna Gómez García, Geert-Jan Brouwers, Frank W G Leebeek, Peter J Koudstaal, Diederik W J Dippel.   

Abstract

BACKGROUND: The relationship between the PIA2 allele of the Leu(33)Pro polymorphism of glycoprotein IIb/IIIa receptor (GPIIb/IIIa) and ischemic stroke is uncertain. The purpose of this study was to investigate a possible association between the GPIIb/IIIa PIA1/A2 polymorphism and the occurrence of cryptogenic stroke in young patients.
METHODS: From a consecutive series of 80 patients aged 45 or less with a recent ischemic stroke or TIA, we selected 45 patients with stroke due to small vessel occlusion or stroke of undetermined etiology (according to the TOAST criteria). Controls were 60 healthy blood donors with a similar age distribution. All patients underwent CT of the brain and were screened for cardiovascular risk factors, cardiac disorders and large vessel disease. The frequency of the PIA2 allele was determined by PCR and Msp1 restriction analysis.
RESULTS: Eight patients (16%) and 16 controls (27%) were heterozygous for PIA2 allele. Two patients (4%) were homozygous for PIA2. The relative risk of ischemic stroke associated with PIA2 allele was estimated at 0.8 (95% CI: 0.3-1.9).
CONCLUSION: This study does not support the association between the PIA1/A2 polymorphism and cryptogenic stroke or TIA in patients aged 45 or less.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12586134     DOI: 10.1016/s0049-3848(02)00356-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

Review 1.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

2.  Thrombophilias and stroke: diagnosis, treatment, and prognosis.

Authors:  Madeline C Fields; Steven R Levine
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

3.  Platelet glycoprotein IIIA PIA1/A2 polymorphism in young patients with ST elevation myocardial infarction and idiopathic ischemic stroke.

Authors:  Blanca Elsa Rivera-García; Juan Carlos Esparza-García; Jose Luis Aceves-Chimal; Alfredo Leaños-Miranda; Abraham Majluf-Cruz; Irma Isordia-Salas
Journal:  Mol Cell Biochem       Date:  2013-09-05       Impact factor: 3.396

Review 4.  Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.

Authors:  Marlene S Williams; Ethan J Weiss; Marc S Sabatine; Daniel I Simon; Wadie F Bahou; Lewis C Becker; Leslie V Parise; Harold L Dauerman; Patricia A French; Susan S Smyth; Richard C Becker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

Review 5.  Genetics of atherothrombotic and lacunar stroke.

Authors:  Stéphanie Debette; Sudha Seshadri
Journal:  Circ Cardiovasc Genet       Date:  2009-04

Review 6.  The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis.

Authors:  Christopher N Floyd; Benjamin H Ellis; Albert Ferro
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.